WisBusiness
WisBusiness.com focuses on economic growth and shares the most recent updates from various businesses throughout Wisconsin, regardless of their size.
Outlet metrics
Global
#2567299
United States
#824897
News and Media
#17300
Articles
-
5 days ago |
wisbusiness.com | Alex Moe
GOP lawmakers are circulating a bill to establish a dairy farm innovation program, which would offer no-interest loans to qualifying milk producers. Sen. Rob Stafsholt of New Richmond and Rep. Clint Moses of Menomonie on Friday sent a cosponsorship memo to other lawmakers detailing the bill. The noted dairy farms in the state are struggling to find workers, limiting their competitiveness, but advancements in technology have enabled greater farm efficiency.
-
5 days ago |
wisbusiness.com | Alex Moe
— GOP lawmakers are circulating a bill to establish a dairy farm innovation program, which would offer no-interest loans to qualifying milk producers. Sen. Rob Stafsholt of New Richmond and Rep. Clint Moses of Menomonie on Friday sent a cosponsorship memo to other lawmakers detailing the bill. The noted dairy farms in the state are struggling to find workers, limiting their competitiveness, but advancements in technology have enabled greater farm efficiency.
-
1 week ago |
wisbusiness.com | Alex Moe
— This week’s episode of “WisBusiness: the Podcast” is with Nikki Johnston, co-founder of N-Zyme Biomedical. The company is developing a new drug treatment for a lesser known form of acid reflux called laryngopharyngeal reflux, or LPR. It affects as many as 20% of Americans, according to figures provided by the business, and no medications currently exist to treat it.
-
1 week ago |
wisbusiness.com | Alex Moe
This week’s episode of “WisBusiness: the Podcast” is with Nikki Johnston, co-founder of N-Zyme Biomedical. The company is developing a new drug treatment for a lesser known form of acid reflux called laryngopharyngeal reflux, or LPR. It affects as many as 20% of Americans, according to figures provided by the business, and no medications currently exist to treat it.
-
1 week ago |
wisbusiness.com | Alex Moe
— Archeus Technologies in Madison and WARF are launching a clinical trial this year for a targeting molecule used in treating prostate cancer. The organizations yesterday announced the plans to further develop ART-101, a receptor-based targeting molecule developed at UW-Madison’s Advanced Radiotheranostics lab. It’s designed to deliver radioactive isotopes within the body as part of a targeted treatment approach.
WisBusiness journalists
Contact details
Address
123 Example Street
City, Country 12345
Phone
+1 (555) 123-4567
Email Patterns
Website
http://wisbusiness.comTry JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →